Long-term peritoneal dialysis (PD) can lead to fibrotic changes in the peritoneum, characterized by loss of mesothelial cells (MCs) and thickening of the submesothelial area with an accumulation of collagen and myofibroblasts. The origin of myofibroblasts is a central question in peritoneal fibrosis that remains unanswered at present. Numerous clinical and experimental studies have suggested that MCs, through epithelial-mesenchymal transition (EMT), contribute to the pool of peritoneal myofibroblasts. However, recent work has placed significant doubts on the paradigm of EMT in organ fibrogenesis (in the kidney particularly), highlighting the need to reconsider the role of EMT in the generation of myofibroblasts in peritoneal fibrosis. In particular, selective cell isolation and lineage-tracing experiments have suggested the existence of progenitor cells in the peritoneum, which are able to switch to fibroblast-like cells when stimulated by the local environment. These findings highlight the plastic nature of MCs and its contribution to peritoneal fibrogenesis. In this review, we summarize the key findings and caveats of EMT in organ fibrogenesis, with a focus on PD-related peritoneal fibrosis, and discuss the potential of peritoneal MCs as a source of myofibroblasts.
JainA.K., BlakeP., CordyP., GargA.X.Global trends in rates of peritoneal dialysis.J Am Soc Nephrol2012; 23: 533–44.
2.
BargmanJ.M.Advances in peritoneal dialysis: a review.Semin Dial2012; 25: 545–9.
3.
DaviesS.J.Peritoneal dialysis—current status and future challenges.Nat Rev Nephrol2013; 9: 399–408.
4.
PletinckA., VanholderR., VeysN., Van BiesenW.Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.Nat Rev Nephrol2012; 8: 542–50.
5.
MargettsP.J., BonniaudP.Basic mechanisms and clinical implications of peritoneal fibrosis.Perit Dial Int2003; 23: 530–41.
6.
DevuystO., MargettsP.J., TopleyN.The pathophysiology of the peritoneal membrane.J Am Soc Nephrol2010; 21: 1077–85.
7.
MassagueJ.TGF-beta signalling in context.Nat Rev Mol Cell Biol2012; 13: 616–30.
8.
WynnT.A., RamalingamT.R.Mechanisms of fibrosis: therapeutic translation for fibrotic disease.Nat Med2012; 18: 1028–40.
9.
GrandeM.T., Lopez-NovoaJ.M.Fibroblast activation and myofibroblast generation in obstructive nephropathy.Nat Rev Nephrol2009; 5: 319–28.
10.
OkadaH., InoueT., KannoY., KobayashiT., WatanabeY., BanS.Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome.Kidney Int2003; 64: 1722–32.
11.
CieslikK.A., TrialJ., CrawfordJ.R., TaffetG.E., EntmanM.L.Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts.J Mol Cell Cardiol2014; 70C: 56–63.
12.
KrenningG., ZeisbergE.M., KalluriR.The origin of fibroblasts and mechanism of cardiac fibrosis.J Cell Physiol2010; 225: 631–7.
13.
BallhauseT.M., SoldatiR., MertensP.R.Sources of myofibroblasts in kidney fibrosis: all answers are correct, however to different extent!Int Urol Nephrol2014; 46: 659–64.
14.
KokuboS., SakaiN., FuruichiK., ToyamaT., KitajimaS., OkumuraT.Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes.Perit Dial Int2012; 32: 10–9.
15.
MutsaersS.E., WilkoszS.Structure and function of mesothelial cells.Cancer Treat Res2007; 134: 1–19.
BirdS.D.Mesothelial primary cilia of peritoneal and other serosal surfaces.Cell Biol Int2004; 28: 151–9.
19.
YungS., ChanT.M.Intrinsic cells: mesothelial cells—central players in regulating inflammation and resolution.Perit Dial Int2009; 29(Suppl 2): S21–7.
20.
SchilteM.N., CelieJ.W., WeeP.M., BeelenR.H., van den BornJ.Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.Perit Dial Int2009; 29: 605–17.
KatoS., YuzawaY., TsuboiN., MaruyamaS., MoritaY., MatsuguchiT.Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.J Am Soc Nephrol2004; 15: 1289–99.
23.
ParkJ.H., KimY.G., ShawM., KannegantiT.D., FujimotoY., FukaseK.Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells.J Immunol2007; 179: 514–21.
24.
LaiK.N., TangS.C., LeungJ.C.Mediators of inflammation and fibrosis.Perit Dial Int2007; 27(Suppl 2): S65–71.
25.
HerrickS.E., MutsaersS.E.Mesothelial progenitor cells and their potential in tissue engineering.Int J Biochem Cell Biol2004; 36: 621–42.
26.
MutsaersS.E.Mesothelial cells: their structure, function and role in serosal repair.Respirology2002; 7: 171–91.
27.
LiY., WangJ., AsahinaK.Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury.Proc Natl Acad Sci USA2013; 110: 2324–9.
28.
CombetS., FerrierM.L., Van LandschootM., StoenoiuM., MoulinP., MiyataT.Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.J Am Soc Nephrol2001; 12: 2146–57.
29.
MargettsP.J., KolbM., YuL., HoffC.M., HolmesC.J., AnthonyD.C.Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.Am J Pathol2002; 160: 2285–94.
30.
KalluriR., NeilsonE.G.Epithelial-mesenchymal transition and its implications for fibrosis.J Clin Invest2003; 112: 1776–84.
31.
AcloqueH., AdamsM.S., FishwickK., Bronner-FraserM., NietoM.A.Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease.J Clin Invest2009; 119: 1438–49.
32.
ThieryJ.P., AcloqueH., HuangR.Y., NietoM.A.Epithelial-mesenchymal transitions in development and disease.Cell2009; 139: 871–90.
33.
NietoM.A.Epithelial plasticity: a common theme in embryonic and cancer cells.Science2013; 342: 1234850.
KalluriR., WeinbergR.A.The basics of epithelial-mesenchymal transition.J Clin Invest2009; 119: 1420–8.
36.
ZeisbergM., NeilsonE.G.Biomarkers for epithelial-mesenchymal transitions.J Clin Invest2009; 119: 1429–37.
37.
XuJ., LamouilleS., DerynckR.TGF-beta-induced epithelial to mesenchymal transition.Cell Res2009; 19: 156–72.
38.
TamW.L., WeinbergR.A.The epigenetics of epithelial-mesenchymal plasticity in cancer.Nat Med2013; 19: 1438–49.
39.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
40.
ChoJ.H., DoJ.Y., OhE.J., RyuH.M., ParkS.Y., KimS.O.Are ex vivo mesothelial cells representative of the in vivo transition from epithelial-to-mesenchymal cells in peritoneal membrane?Nephrol Dial Transplant2012; 27: 1768–79.
41.
AguileraA., Yanez-MoM., SelgasR., Sanchez-MadridF., Lopez-CabreraM.Epithelial-to-mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.Curr Opin Investig Drugs2005; 6: 262–8.
42.
SelgasR., BajoA., Jimenez-HeffernanJ.A., Sanchez-TomeroJ.A., Del PesoG., AguileraA.Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis.Nephrol Dial Transplant2006; 21(Suppl 2): ii2–7.
43.
AroeiraL.S., AguileraA., Sanchez-TomeroJ.A., BajoM.A., del PesoG., Jimenez-HeffernanJ.A.Epithelial-to-mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.J Am Soc Nephrol2007; 18: 2004–13.
44.
KimY.L.Update on mechanisms of ultrafiltration failure.Perit Dial Int2009; 29(Suppl 2): S123–7.
45.
LanH.Y., ChungA.C.TGF-β/Smad signaling in kidney disease.Semin Nephrol2012; 32: 236–43.
46.
SamarakoonR., OverstreetJ.M., HigginsP.J.TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities.Cell Signal2013; 25: 264–8.
47.
VerrecchiaF., ChuM.L., MauvielA.Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach.J Biol Chem2001; 276: 17058–62.
ZhouQ., YangM., LanH., YuX.miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1.Am J Pathol2013; 183: 808–19.
50.
HiraharaI., IshibashiY., KanameS., KusanoE., FujitaT.Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.Nephrol Dial Transplant2009; 24: 437–47.
51.
LiuQ., MaoH., NieJ., ChenW., YangQ., DongX.Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.Perit Dial Int2008; 28(Suppl 3): S88–95.
52.
MargettsP.J., BonniaudP., LiuL., HoffC.M., HolmesC.J., West-MaysJ.A.Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.J Am Soc Nephrol2005; 16: 425–36.
53.
LeiP., JiangZ., ZhuH., LiX., SuN., YuX.Poly (ADP-ribose) polymerase-1 in high glucose-induced epithelial-mesenchymal transition during peritoneal fibrosis.Int J Mol Med2012; 29: 472–8.
54.
BajoM.A., Perez-LozanoM.L., Albar-VizcainoP., del PesoG., CastroM.J., Gonzalez-MateoG.Low-GDP peritoneal dialysis fluid (‘balance’) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid.Nephrol Dial Transplant2011; 26: 282–91.
55.
YuM.A., ShinK.S., KimJ.H., KimY.I., ChungS.S., ParkS.H.HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.J Am Soc Nephrol2009; 20: 567–81.
56.
XiaoL., SunL., LiuF.Y., PengY.M., DuanS.B.Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.Ther Apher Dial2010; 14: 27–34.
57.
ItoT., YoriokaN., YamamotoM., KataokaK., YamakidoM.Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells.J Am Soc Nephrol2000; 11: 1969–79.
58.
LeeS.H., KangH.Y., KimK.S., NamB.Y., PaengJ., KimS.The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells.Lab Invest2012; 92: 1698–711.
59.
StrippoliR., BenedictoI., Perez LozanoM.L., PellinenT., SandovalP., Lopez-CabreraM.Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial-to-mesenchymal transition of mesothelial cells.PLoS One2012; 7: e31492.
60.
StrippoliR., BenedictoI., ForondaM., Perez-LozanoM.L., Sanchez-PeralesS., Lopez-CabreraM.p38 maintains E-cadherin expression by modulating TAK1-NF-kappa b during epithelial-to-mesenchymal transition.J Cell Sci2010; 123: 4321–31.
61.
ErtilavM., TimurO., HurE., BozkurtD., NarH., KologluT.What does the dialysate level of matrix metalloproteinase 2 tell us?Adv Perit Dial2011; 27: 6–10.
62.
YangA.H., ChenJ.Y., LinJ.K.Myofibroblastic conversion of mesothelial cells.Kidney Int2003; 63: 1530–9.
63.
PatelP., SekiguchiY., OhK.H., PattersonS.E., KolbM.R., MargettsP.J.Smad3-dependent and -independent pathways are involved in peritoneal membrane injury.Kidney Int2010; 77: 319–28.
64.
LiuQ., ZhangY., MaoH., ChenW., LuoN., ZhouQ.A crosstalk between the Smad and JNK signaling in the TGF-β–induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.PLoS One2012; 7: e32009.
65.
ZhangF., LiuH., LiuF., PengY., ChenM., LiuY.New insights into the pathogenesis and treatment of peritoneal fibrosis: a potential role of Wnt/β–catenin induced epithelial-to-mesenchymal transition and stem cells for therapy.Med Hypotheses2013; 81: 97–100.
66.
LuoL., LiuH., DongZ., SunL., PengY., LiuF.Small interfering RNA targeting ILK inhibits EMT in human peritoneal mesothelial cells through phosphorylation of GSK3β.Mol Med Rep2014; 10: 137–44.
67.
StrippoliR., BenedictoI., Perez LozanoM.L., CerezoA., Lopez-CabreraM., del PozoM.A.Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.Dis Model Mech2008; 1: 264–74.
68.
JangY.H., ShinH.S., Sun ChoiH., RyuE.S., Jin KimM., Ki MinS.Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.Lab Invest2013; 93: 194–206.
69.
Del PesoG., Jimenez-HeffernanJ.A., BajoM.A., AroeiraL.S., AguileraA., Fernandez-PerpenA.Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.Kidney Int (Suppl)2008: S26–33.
70.
Jimenez-HeffernanJ.A., AguileraA., AroeiraL.S., Lara-PezziE., BajoM.A., del PesoG.Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis.Virchows Arch2004; 444: 247–56.
71.
DoJ.Y., KimY.L., ParkJ.W., ChoK.H., KimT.W., YoonK.W.The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients.Perit Dial Int2005; 25(Suppl 3): S22–5.
72.
AroeiraL.S., AguileraA., SelgasR., Ramirez-HuescaM., Perez-LozanoM.L., CirugedaA.Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.Am J Kidney Dis2005; 46: 938–48.
73.
OhE.J., RyuH.M., ChoiS.Y., YookJ.M., KimC.D., ParkS.H.Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.Am J Nephrol2010; 31: 58–67.
74.
PletinckA., ConsoliC., Van LandschootM., SteppanS., TopleyN., Passlick-DeetjenJ.Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats.Nephrol Dial Transplant2010; 25: 1688–96.
ChauB.N., XinC., HartnerJ., RenS., CastanoA.P., LinnG.MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.Sci Transl Med2012; 4: 121ra18.
82.
QinW., ChungA.C., HuangX.R., MengX.M., HuiD.S., YuC.M.TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.J Am Soc Nephrol2011; 22: 1462–74.
83.
LiR., ChungA.C., DongY., YangW., ZhongX., LanH.Y.The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.Kidney Int2013; 84: 1129–44.
84.
LorenzenJ.M., HallerH., ThumT.MicroRNAs as mediators and therapeutic targets in chronic kidney disease.Nat Rev Nephrol2011; 7: 286–94.
85.
PatelV., NoureddineL.MicroRNAs and fibrosis.Curr Opin Nephrol Hyper-tens2012; 21: 410–6.
86.
ZhangK., ZhangH., ZhouX., TangW.B., XiaoL., LiuY.H.miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells.J Biomed Biotechnol2012; 2012: 673096.
87.
GuoF., GopaulD.N., van DuyneG.D.Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse.Nature1997; 389: 40–6.
88.
NagyA.Cre recombinase: the universal reagent for genome tailoring.Genesis2000; 26: 99–109.
89.
HumphreysB.D., DiRoccoD.P.Lineage-tracing methods and the kidney.Kidney Int2014; 86: 481–8.
90.
IwanoM., PliethD., DanoffT.M., XueC., OkadaH., NeilsonE.G.Evidence that fibroblasts derive from epithelium during tissue fibrosis.J Clin Invest2002; 110: 341–50.
91.
ZeisbergM., YangC., MartinoM., DuncanM.B., RiederF., TanjoreH.Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.J Biol Chem2007; 282: 23337–47.
92.
KimK.K., KuglerM.C., WoltersP.J., RobillardL., GalvezM.G., BrumwellA.N.Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.Proc Natl Acad Sci USA2006; 103: 13180–5.
93.
FlierS.N., TanjoreH., KokkotouE.G., SugimotoH., ZeisbergM., KalluriR.Identification of epithelial-to-mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.J Biol Chem2010; 285: 20202–12.
94.
SaikaS., Kono-SaikaS., OhnishiY., SatoM., MuragakiY., OoshimaA.Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury.Am J Pathol2004; 164: 651–63.
95.
CarewR.M., WangB., KantharidisP.The role of EMT in renal fibrosis.Cell Tissue Res2012; 347: 103–16.
96.
HillsC.E., SquiresP.E.The role of TGF-β and epithelial-to-mesenchymal transition in diabetic nephropathy.Cytokine Growth Factor Rev2011; 22: 131–9.
97.
FragiadakiM., MasonR.M.Epithelial-mesenchymal transition in renal fibrosis—evidence for and against.Int J Exp Pathol2011; 92: 143–50.
98.
QuagginS.E., KapusA.Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition.Kidney Int2011; 80: 41–50.
99.
LiuY.New insights into epithelial-mesenchymal transition in kidney fibrosis.J Am Soc Nephrol2010; 21: 212–22.
RobertsA.B., TianF., ByfieldS.D., StueltenC., OoshimaA., SaikaS.Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.Cytokine Growth Factor Rev2006; 17: 19–27.
102.
StrutzF., OkadaH., LoC.W., DanoffT., CaroneR.L., TomaszewskiJ.E.Identification and characterization of a fibroblast marker: FSP1.J Cell Biol1995; 130: 393–405.
103.
VenkovC.D., LinkA.J., JenningsJ.L., PliethD., InoueT., NagaiK.A proximal activator of transcription in epithelial-mesenchymal transition.J Clin Invest2007; 117: 482–91.
104.
ChengS., LovettD.H.Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.Am J Pathol2003; 162: 1937–49.
105.
McMorrowT., GaffneyM.M., SlatteryC., CampbellE., RyanM.P.Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.Nephrol Dial Transplant2005; 20: 2215–25.
CarvajalG., DroguettA., BurgosM.E., ArosC., ArdilesL., FloresC.Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy.Transplant Proc2008; 40: 734–9.
112.
SimonsonM.S.Phenotypic transitions and fibrosis in diabetic nephropathy.Kidney Int2007; 71: 846–54.
113.
KrizW., KaisslingB., Le HirM.Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?J Clin Invest2011; 121: 468–74.
114.
Le HirM., HegyiI., Cueni-LoffingD., LoffingJ., KaisslingB.Characterization of renal interstitial fibroblast-specific protein 1/s100a4-positive cells in healthy and inflamed rodent kidneys.Histochem Cell Biol2005; 123: 335–46.
115.
PicardN., BaumO., VogetsederA., KaisslingB., Le HirM.Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat.Histochem Cell Biol2008; 130: 141–55.
116.
RossiniM., CheunsuchonB., DonnertE., MaL.J., ThomasJ.W., NeilsonE.G.Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease.Kidney Int2005; 68: 2621–8.
117.
LiL., Zepeda-OrozcoD., BlackR., LinF.Autophagy is a component of epithelial cell fate in obstructive uropathy.Am J Pathol2010; 176: 1767–78.
118.
GroneH.J., WeberK., GroneE., HelmchenU., OsbornM.Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney.Am J Pathol1987; 129: 1–8.
119.
WitzgallR., BrownD., SchwarzC., BonventreJ.V.Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells.J Clin Invest1994; 93: 2175–88.
120.
HumphreysB.D., LinS.L., KobayashiA., HudsonT.E., NowlinB.T., BonventreJ.V.Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.Am J Pathol2010; 176: 85–97.
121.
LinS.L., KisselevaT., BrennerD.A., DuffieldJ.S.Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney.Am J Pathol2008; 173: 1617–27.
122.
KoestersR., KaisslingB., LehirM., PicardN., TheiligF., GebhardtR.Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells.Am J Pathol2010; 177: 632–43.
123.
LeBleuV.S., TaduriG., O'ConnellJ., TengY., CookeV.G., WodaC.Origin and function of myofibroblasts in kidney fibrosis.Nat Med2013; 19: 1047–53.
124.
DuffieldJ.S.Cellular and molecular mechanisms in kidney fibrosis.J Clin Invest2014; 124: 2299–306.
125.
ChenY.T., ChangY.T., PanS.Y., ChouY.H., ChangF.C., YehP.Y.Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.J Am Soc Nephrol2014.
126.
AsahinaK., ZhouB., PuW.T., TsukamotoH.Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver.Hepatology2011; 53: 983–95.
PatelP., West-MaysJ., KolbM., RodriguesJ.C., HoffC.M., MargettsP.J.Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.Matrix Biol2010; 29: 97–106.
129.
KeatingA.Mesenchymal stromal cells: new directions.Cell Stem Cell2012; 10: 709–16.
130.
FrenetteP.S., PinhoS., LucasD., ScheiermannC.Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine.Annu Rev Immunol2013; 31: 285–316.
131.
BolenJ.W., HammarS.P., McNuttM.A.Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study.Am J Surg Pathol1986; 10: 34–47.
132.
BolenJ.W., HammarS.P., McNuttM.A.Serosal tissue: reactive tissue as a model for understanding mesotheliomas.Ultrastruct Pathol1987; 11: 251–62.
133.
WadaA.M., SmithT.K., OslerM.E., ReeseD.E., BaderD.M.Epicardial/mesothelial cell line retains vasculogenic potential of embryonic epicardium.Circ Res2003; 92: 525–31.
134.
Perez-PomaresJ.M., CarmonaR., Gonzalez-IriarteM., AtenciaG., WesselsA., Munoz-ChapuliR.Origin of coronary endothelial cells from epicardial mesothelium in avian embryos.Int J Dev Biol2002; 46: 1005–13.
135.
WesselsA., Perez-PomaresJ.M.The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells.Anat Rec A Discov Mol Cell Evol Biol2004; 276: 43–57.
136.
van TuynJ., AtsmaD.E., WinterE.M., van der Velde-van DijkeI., PijnappelsD.A., BaxN.A.Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro.Stem Cells2007; 25: 271–8.
137.
ZhouB., MaQ., RajagopalS., WuS.M., DomianI., Rivera-FelicianoJ.Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart.Nature2008; 454: 109–13.
SmartN., BolliniS., DubeK.N., VieiraJ.M., ZhouB., DavidsonS.De novo cardiomyocytes from within the activated adult heart after injury.Nature2011; 474: 640–4.
141.
Gittenberger-de GrootA.C., WinterE.M., PoelmannR.E.Epicardium-derived cells (EPDCs) in development, cardiac disease and repair of ischemia.J Cell Mol Med2010; 14: 1056–60.
142.
LimanaF., CapogrossiM.C., GermaniA.The epicardium in cardiac repair: from the stem cell view.Pharmacol Ther2011; 129: 82–96.
143.
Gittenberger-de GrootA.C., WinterE.M., BartelingsM.M., GoumansM.J., DeRuiterM.C., PoelmannR.E.The arterial and cardiac epicardium in development, disease and repair.Differentiation2012; 84: 41–53.
144.
SmartN., DubeK.N., RileyP.R.Epicardial progenitor cells in cardiac regeneration and neovascularisation.Vascul Pharmacol2013; 58: 164–73.
145.
RileyP.R., SmartN.Thymosin beta4 induces epicardium-derived neovascularization in the adult heart.Biochem Soc Trans2009; 37: 1218–20.
146.
SmartN., BolliniS., DubeK.N., VieiraJ.M., ZhouB., RieglerJ.Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.Ann N Y Acad Sci2012; 1269: 92–101.
147.
ChenS., ShimodaM., ChenJ., GrayburnP.A.Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery.Gene Ther2013; 20: 225–33.
148.
RinkevichY., MoriT., SahooD., XuP.X., BerminghamJ.R.Jr., WeissmanI.L.Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature.Nat Cell Biol2012; 14: 1251–60.
149.
ZeisbergM., DuffieldJ.S.Resolved: EMT produces fibroblasts in the kidney.J Am Soc Nephrol2010; 21: 1247–53.
